The most commonly used gene expression profile test, Oncotype DX®, used to help predict breast cancer recurrence may not be as cost-effective as once thought, say a team of researchers.
from Latest Science News -- ScienceDaily http://ift.tt/2D9M2Vw
via IFTTT
Featured Post
Indian Army's Srinagar-based Chinar Corps on Thursday felicitated Sabkat
Indian Army's Srinagar-based Chinar Corps on Thursday felicitated Sabkat Malik from Wajhera, Bandipora for qualifying in Jiu Jitsu Worl...
-
The US Senate has voted to reopen the government, ending a days-long standoff that has forced hundreds of thousands of workers to stay at ho...
-
Mehak Bashir of class 6th from GURU NANAK DEV MODEL HIGH SCHOOL BARAMULLA bagged a Gold Medal in KICK Boxing at National level. This award ...
0 comments:
Post a Comment